Biotech · Private company
Bellerophon
Track this companyFree. Adds Bellerophon to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- iNOPhase 2 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- INOpulse®Phase 2 · Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Long Term Follow UpPhase 2 · Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Inhaled Nitric Oxide for Preventing Progression in COVID-19PHASE2 · TERMINATED · started May 12, 2020ClinicalTrials.gov NCT04388683 · fetched Nov 12, 2026
- A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or SarcoidosisPHASE2 · COMPLETED · started Jan 30, 2019ClinicalTrials.gov NCT03727451 · fetched Nov 12, 2026
- A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisPHASE2 · UNKNOWN · started Dec 29, 2017ClinicalTrials.gov NCT05747508 · fetched Nov 12, 2026